刘珊珊;刘晓谦;田双双;朱晶晶;高慧敏;闫利华;王智民;高陆;
LIU Shan-shan;LIU Xiao-qian;TIAN Shuang-shuang;ZHU Jing-jing;GAO Hui-min;YAN Li-hua;WANG Zhi-min;GAO Lu;National Engineering Laboratory for Quality Control Technology of Chinese Herbal Medicines, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences;Xiuzheng Pharmaceutical Group Co., Ltd.;

• 1:中国中医科学院中药研究所中药质量控制技术国家工程实验室
• 2:修正药业集团股份有限公司

摘要(Abstract)：

该文通过UPLC-Q-TOF-MS指认了泽泻水提物中核苷、氨基酸等10个成分。首次建立了泽泻药材中核苷类成分的HPLC指纹图谱,结合指纹图谱相似度评价、聚类分析比较核苷类成分在不同产地泽泻药材中的差异。同时首次建立泽泻药材中5种主要核苷(胞苷、尿苷、腺嘌呤、鸟苷、腺苷)的含量测定方法。结果显示,川泽泻与建泽泻的相似度在0.96以上,广泽泻相似度小于0.87;聚类分析中川泽泻与建泽泻聚为一组,广泽泻聚为另一组,提示在核苷类成分上川泽泻与建泽泻较为相似,与广泽泻差异较大。含量测定结果显示,川泽泻与建泽泻上述5种成分质量分数总和为0.81～1.30 mg·g~(-1),广泽泻为0.35～0.50 mg·g~(-1)。在川泽泻与建泽泻药材中含量由高到低依次为鸟苷>胞苷>尿苷>腺嘌呤>腺苷;在广泽泻中依次为尿苷>腺嘌呤>鸟苷>胞苷>腺苷。川泽泻与建泽泻中上述5种化合物的含量均高于广泽泻;川泽泻与建泽泻相比,除腺嘌呤外,均为川泽泻略高于建泽泻。研究结果为进一步揭示泽泻药效物质及药材质量的全面控制提供参考。
Ten compounds, including nucleosides and amino acids were identified by UPLC-Q-TOF-MS. HPLC fingerprints on these compounds in Alismatis Rhizoma were established for the first time. The comparisons of Alismatis Rhizoma from different regions were conducted by the similarity evaluation and hierarchical cluster analysis(HCA). Meanwhile, the HPLC-DAD method for the content determination of five nucleosides was also established. The results showed that the similarities of Alismatis Rhizoma collected from Sichuan and Fujian provinces were above 0.96, whereas they were less than 0.87 in those from Guangxi province. The results of HCA showed the samples from Sichuan and Fujian were gathered in the same group, all samples from Guangxi in another group, which indicated the similarities between samples from Sichuan and Fujian in nucleosides and they were different from the samples from Guangxi. The total contents of five nucleosides were revealed, of which samples from Sichuan and Fujian were 0.81-1.30 mg·g~(-1) followed a descending order of vernine>cytidine>uridine>adenine>adenosine, and from Guangxi were 0.35-0.50 mg·g~(-1) with the sequences of uridine>adenine>vernine>cytidine>adenosine. The nucleosides contents of samples from Sichuan and Fujian were both higher than that from Guangxi. For samples from Sichuan and Fujian, the former was slightly higher, except for adenine. These results would be helpful to reveal the bioactive constituents in aqueous extract and provided important evidences for the quality control of Alismatis Rhizoma.

关键词(KeyWords)： 泽泻;核苷;指纹图谱;含量测定
Alismatis Rhizoma;nucleosides;fingerprint;contents determination

Abstract:

Keywords:

基金项目(Foundation): 国家中药标准化项目(ZYBZH-C-JL-24);; 国家药典委员会标准制修订研究课题(2018Z079)

作者(Author): 刘珊珊;刘晓谦;田双双;朱晶晶;高慧敏;闫利华;王智民;高陆;
LIU Shan-shan;LIU Xiao-qian;TIAN Shuang-shuang;ZHU Jing-jing;GAO Hui-min;YAN Li-hua;WANG Zhi-min;GAO Lu;National Engineering Laboratory for Quality Control Technology of Chinese Herbal Medicines, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences;Xiuzheng Pharmaceutical Group Co., Ltd.;

Email:

DOI: 10.19540/j.cnki.cjcmm.20190621.201

参考文献(References)：

• [1] 国家药典委员会.中华人民共和国药典.一部[S].北京:中国医药科技出版社,2015:229.
• [2] 蔡沓栗,杨成梓,温秀萍,等.泽泻的资源调查及外观性状评价[J].中国现代中药,2016,18(2):193.
• [3] SHU Z,PU J,CHEN L,et al.Alisma orientale:ethnopharmacology,phytochemistry and pharmacology of an important traditional Chinese medicine [J].Am J Chin Med,2016,44(2):227.
• [4] ZHANG L L,XU W,XU Y L,et al.Therapeutic potential of Rhizoma Alismatis:a review on ethnomedicinal application,phytochemistry,pharmacology,and toxicology [J].Ann N Y Acad Sci,2017,1401(1):90.
• [5] 吴水生.泽泻的药学与临床研究[M].北京:中国中医药出版社,2009.
• [6] 邰艳妮,吴献,樊李明,等.UPLC-MS/MS法同时测定泽泻药材中16个成分[J].药物分析杂志,2018,38(8):1337.
• [7] WU J,YANG W,PAN H,et al.Geographic impact evaluation of the quality of Alismatis Rhizoma by untargeted metabolomics and quantitative assay [J].J Sep Sci,2018,41(4):839.
• [8] 吴镜湘,徐美英.腺苷心肌保护作用研究进展[J].中国心血管杂志,2002,7(5):364.
• [9] HEADRICK J P,PEART J N,REICHELT M E,et al.Adenosine and its receptors in the heart:regulation,retaliation and adaptation [J].Biochim Biophys Acta,2011,1808(5):1413.
• [10] 蒲泽锦,周小涛,李国平,等.腺苷对肝癌细胞自噬和增殖的作用[J].中国药理学通报,2018,34(4):508.
• [11] KINAHAN J J,KOWAL E P,GRINDEY G B.Biochemical and antitumor effects of the combination of thymidine and 1-beta-D-arabinofuranosylcytosine against leukemia L1210 [J].Cancer Res,1981,41(2):445.
• [12] 王冬梅,刘景汉,周俊,等.腺苷对血小板体外激活的抑制作用[J].中国实验血液学杂志,2005,13(6):1094.
• [13] MORIMOTO C,STEINBERG A D,SCHLOSSMAN S F,et al.In vitro nucleoside specific immune response by lymphocytes from systemic lupus erythematosus [J].J Clin Invest,1983,71(5):1402.
• [14] 昝珂,黄莉莉,过立农,等.基于特征图谱及多指标成分含量的冬虫夏草野生与人工繁育品比较研究[J].中国中药杂志,2017,42(20):3957.
• [15] 周恒,曹依敏,苗水,等.HPLC法测定沪地龙中7个核苷类成分的含量[J].药物分析杂志,2018,38(1):97.
• [16] 张琪,朱叶华,文红梅,等.HPLC-PDA同时测定不同品种及产地蜈蚣中8种核苷类成分[J].中国实验方剂学杂志,2017,23(14):57.
• [17] 王朋展,相美容,李灿,等.HPLC法同时测定不同来源半夏及其伪品中9种核苷类成分的含量[J].药物分析杂志,2017,37(2):212.
• [18] 马鹏,王丽,孙年喜,等.HPLC-DAD同时测定太白贝母中9种核苷类成分的含量[J].中药材,2016,9(1):124.
• [19] 赵万里,黄小强,许文,等.RP-HPLC-DAD同时测定泽泻中11个三萜类成分[J].中草药,2016,47(16):2933.
• [20] 吴水生,陈菁瑛,黄泽豪,等.从植物分类学及分子生物学角度区分建泽泻与川泽泻[C].凯里:全国第8届天然药物资源学术研讨会,2008.
• [21] 邰艳妮,翁艳鸿,张苏萍,等.一测多评法测定不同等级泽泻药材中7个萜类成分的含量[J].中国中药杂志,2019,44(11):2292.